Patients will face delays in getting diagnostic scans due to severe shortage of imaging agentsSeptember 08, 2008Letter: Medical isotope supplies and nuclear medicine services A global shortage of medical isotopes* used in over 80% of routine diagnostic nuclear imaging procedures such as heart imaging, bone scans and some cancer detection procedures, will cause delays and cancellations to diagnostic examinations across the UK and Europe in the next few weeks, predict experts on bmj.com today. UK hospitals are receiving less than 50% of expected supplies and rations are expected to drop still further in the coming weeks, write Alan Perkins and colleagues from the British Nuclear Medicine Society. According to the European Association of Nuclear Medicine European hospitals are already limited to only 20��% of normal nuclear medical activities. The authors warn that if NHS managers in the UK aim to meet the six-week target for diagnostic waiting times by altering bookings on the basis of waiting times rather than clinical priority, some patients may receive sub-optimal treatment. Currently Europe's three isotope production reactors are all shut down because of maintenance issues and European producers only have enough radioisotopes to last until September 8. In addition, other reactors in Canada and South Africa have also been temporarily closed, leaving just the Australian reactor which, according to the authors, does not have enough potential to significantly increase supply to the world market. The closure of the Canadian reactor for two months in 2007 for safety reasons affected over 50 000 patient examinations in the US. The authors point out that this is not just a short term emergency. Most of the commercial reactors are around 40 years old and new production capacity is urgently needed to meet the increasing demands of isotopes for research, diagnosis and treatment. They warn that urgent global investment in new reactor facilities is essential or these problems will continue and it will be the patients that suffer. BMJ-British Medical Journal |
|||||||||||||||||||||
| Related Nuclear Medicine Current Events and Nuclear Medicine News Articles Molecular imaging holds promise for early intervention in common uterine cancer A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. World's most sensitive astronomical camera developed at the Universite de Montreal A team of Université de Montréal researchers, led by physics PhD student Olivier Daigle, has developed the world's most sensitive astronomical camera. Comprehensive cardiac CT scan may give clearer picture of significant heart disease A team of researchers led by Massachusetts General Hospital (MGH) radiologists has developed a computed-tomography-based protocol that identifies both narrowing of coronary arteries and areas of myocardial ischemia - restricted blood flow to heart muscle tissue - giving a better indication of clinically significant coronary artery disease. Worldwide isotope shortage continues to pose significant challenges SNM recently conducted a survey of nuclear pharmacies-pharmacies that supply the critical radioisotope Technetium-99m, which is used in more than 16 million nuclear medicine tests each year in the United States-to assess, anecdotally, the impact of the worldwide medical isotope shortage. PET/CT scans may help detect recurring prostate cancer earlier A new study published in the September issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET)/computer tomography (CT) scans with the imaging agent choline could detect recurring prostate cancer sooner than conventional imaging technologies in some patients who have had their prostates surgically removed. New treatment in sight for ovarian cancer In the future, women with metastatic ovarian cancer could be treated with a radioactive substance that can seek and destroy tumour cells. Blood-flow metabolism mismatch predicts pancreatic tumor aggressiveness Researchers from Turku, Finland, have identified a blood-flow glucose consumption mismatch that predicted pancreatic tumor aggressiveness, according to results of a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research. PET Can Help Guide Treatment Decisions for a Common Pediatric Cancer A new study published in the August issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) is an important tool for depicting the extent of neuroblastoma in some patients, particularly for those in the early stages of the disease. High calcium level in arteries may signal serious heart attack risk Researchers may be able to predict future severe cardiac events in patients with known, stable coronary artery disease (CAD) using coronary calcium scoring, according to a study published in the online edition of Radiology. Study shows PET can measure effectiveness of novel breast cancer treatment A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended. More Nuclear Medicine Current Events and Nuclear Medicine News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||